Bladder Infection? It May Increase Prostate Cancer Risk

Article Summary
- One in eight men will be diagnosed with prostate cancer at some point in their lifetime.
- Various factors contribute to the development of prostate cancer, and studies show bladder infection is one of them.
- Therefore, you need to be proactive about your health and never ignore lower urinary tract symptoms, especially with repeated UTIs.
A bladder infection can feel like nothing more than a minor inconvenience. For most people, antibiotics clear it up and it never comes back. But if you’re a man over 50, a bladder infection, also called cystitis, may be carrying a signal worth taking seriously. A growing body of research suggests that bladder infection may increase prostate cancer risk, particularly in the months right after diagnosis.
This article explains what the research actually shows, how infection and prostate cancer may be connected, and what steps are worth taking next.
Does a Bladder Infection Really Increase Your Prostate Cancer Risk?
Yes, the evidence suggests it does, especially in the short term. Men diagnosed with acute cystitis face an elevated risk of urogenital cancers, including prostate cancer, in the period following infection. The risk appears sharpest within three months of the initial bladder infection, which points to cystitis as a potential clinical marker for a cancer that was already present, rather than a direct cause in every case.
If you’ve ever wondered whether recurrent UTIs and cancer might be connected, the short answer is: yes, and the evidence is stronger than most men realize. Understanding the full picture around prostate cancer causes helps place this risk in context.
What the current evidence shows
A 2025 Swedish nationwide cohort study published in BMJ Public Health analyzed data from over 3.5 million individuals. Among men diagnosed with acute cystitis, urogenital cancer risks were elevated across all age groups. The researchers noted that a bladder infection may signal cancer risk and recommended cystitis be treated as a clinical marker for urogenital malignancy, particularly when the infection has no clear bacterial explanation.
Why this connection matters
Prostate cancer is the most commonly diagnosed urological cancer in men. The Lancet Commission projects global incidence will double to 2.9 million cases by 2040. Identifying earlier markers, including bladder infection history, matters for getting men into screening sooner.
How Bladder Infections and Prostate Health Are Connected
The prostate sits directly below the bladder and wraps around part of the urethra. That anatomy means the urinary tract and prostate health are tightly connected. The bladder infection vs UTI distinction matters here: cystitis inflames the bladder wall, but bacteria in the lower urinary tract can reach prostate tissue through microbial translocation.
Urinary tract infections in men often involve the prostate to some degree, and the two conditions share overlapping bacterial causes.
What happens during a bladder infection
When bacteria, most commonly E. coli, colonize the bladder, they trigger an inflammatory response. The bladder wall becomes swollen and irritated. In men, that inflammation can extend to the prostate through direct contact or through urine reflux into the prostatic ducts.
How infection and inflammation may affect your prostate
Chronic inflammation in prostate tissue creates microenvironmental changes that researchers believe drive carcinogenesis. A 2024 study in The Prostate found that microbial metabolites activate inflammatory signaling pathways, including NF-κB, that have been tied to cancer cell proliferation. Separately, a 2024 analysis in Cancer Medicine noted that bacterial factors in the urinary tract may influence hormonal signaling relevant to prostate cancer risk. Repeated swelling and tissue irritation can shift the local prostate environment in ways that make abnormal cell growth more likely over time. That’s the proposed mechanism; it’s biologically plausible, but much of the supporting data still comes from observational and preclinical work.
What Research Actually Shows About Bladder Infections and Cancer Risk
The evidence linking cystitis to urogenital cancer risk, including prostate and bladder cancer, is primarily observational. That’s an important distinction: this research doesn’t prove that bladder infections cause prostate cancer; it shows the two conditions co-occur at higher-than-expected rates.
The studies examining this link
The 2025 Swedish cohort remains the most statistically powered study on this question. Among men in that dataset, cystitis raised urogenital cancer risk most sharply within three months of diagnosis, with a standardized incidence ratio for bladder cancer of 33.69 in that window. A 2017 PLOS ONE nationwide cohort also found elevated prostate cancer risk in men with a lower urinary tract infection history. A 2023 PMC review confirmed that prostate cancer patients face higher UTI susceptibility than the general population, suggesting a bidirectional relationship. A 2025 British Journal of Cancer population-based case-control study found that lower urinary tract symptoms, including recurrent infections, were tied to subsequent prostate cancer workup. And a 2025 ASCO analysis found that UTIs worsened in-hospital outcomes in men already carrying a prostate cancer diagnosis.
Recurrent infections appear to matter separately. A 2014 British Journal of Cancer study found that recurrent UTIs were associated with bladder cancer risk, and a 2025 Research and Reports in Urology analysis extended that picture to repeat infections and prostate tissue changes. The proposed mechanism for repeat infections is repeated cycles of inflammation that slowly alter the prostate microenvironment over years. The connection between infection and cancer is not unique to the prostate; chronic infection and inflammation are recognized contributors to several cancer types.
How strong is the evidence
It’s suggestive, not conclusive. The three-month risk window almost certainly reflects surveillance bias: men diagnosed with cystitis get more urological tests, so cancers that were already developing get detected sooner. Longer-term risk data are less dramatic. This doesn’t mean the connection is unimportant, but it does mean a single bladder infection isn’t a cancer diagnosis. Larger, more rigorously controlled studies are still needed.
Other Factors That Affect Your Prostate Cancer Risk
Bladder infection history sits alongside a much larger set of established prostate cancer risk factors. Age is the strongest: most cases occur in men over 60. Family history and race also carry significant weight, with Black men facing disproportionately higher incidence rates according to global prostate cancer statistics. Diet, obesity, and physical inactivity are modifiable contributors. Conditions that raise infection susceptibility, such as type 2 diabetes and poorly controlled hypertension, may compound overall risk, according to the 2024 GBD urological disease analysis in Military Medical Research. Bladder infection history is one piece of a larger picture. It’s not a standalone verdict.
When to See a Doctor About Bladder Infections
Any man over 50 who develops a bladder infection should talk with his doctor, not just about treating the infection, but about whether prostate screening is warranted. That’s particularly true for a first infection with no clear cause, or one that doesn’t respond to a standard antibiotic course. Knowing the signs of UTI in men makes it easier to act early. And if you’ve had recurrent UTIs, defined as two or more infections in six months, that pattern warrants a direct conversation about PSA testing and urological evaluation.
Red flags that need immediate attention
See a doctor promptly if you notice bladder cancer symptoms such as blood in your urine, lower back or pelvic pain, difficulty starting urination, or a fever alongside urinary symptoms. A 2025 Medscape analysis found that lower urinary tract symptoms are often undertriaged in men, delaying important cancer workups. A 2024 BMC Microbiology study also confirmed that urinary microbiota analysis can support earlier cancer detection alongside standard diagnostics.
How to prevent recurrent infections
Stay well-hydrated; diluted urine reduces bacterial concentration in the bladder. Urinate fully each time, since incomplete emptying leaves bacteria an environment to grow. Consistent habits around UTI prevention after sex also reduce the frequency of recurrent infections in men with active sex lives. If you have an enlarged prostate, managing it actively reduces the urinary stasis that feeds infections. Your doctor may also recommend a urology referral after two or more infections in a single year.
Protecting Your Prostate Health
The long-term risk picture beyond the first three months post-infection is more modest than the acute window, but it’s still real. Chronic low-grade inflammation, driven by repeated infections over years, likely contributes more than any single episode does. The most practical protective approach combines several things: reducing prostate cancer risk factors through diet and lifestyle, preventing future UTIs through consistent habits, and staying on top of blood sugar control if metabolic health is a concern, since uncontrolled blood sugar feeds infection risk in a cycle that’s hard to break without addressing both. Lifestyle approaches to metabolic health can also bring down systemic inflammation. A 2025 Frontiers in Public Health global trend analysis found that lifestyle factors account for a meaningful share of rising prostate cancer incidence worldwide.
Frequently Asked Questions
Can a single bladder infection cause prostate cancer?
No single infection causes prostate cancer. The elevated risk seen in studies likely reflects underlying inflammation and, in some cases, detection of cancers that were already developing. A single infection is a reason to stay vigilant, not to panic.
Does cystitis always mean I need a prostate exam?
Not necessarily, but men over 50 with a new or unexplained bladder infection should discuss prostate screening with their doctor. The recommendation is stronger if the infection is recurrent or doesn’t have a clear cause.
What’s the difference between a UTI and cystitis?
Cystitis is a specific type of urinary tract infection that targets the bladder. All cystitis is a UTI, but not all UTIs are cystitis, UTIs can also affect the urethra, ureters, or kidneys. The two terms get used interchangeably in everyday conversation, but they don’t mean the same thing.
How soon after a bladder infection should I get checked?
If you’re over 50 and develop a bladder infection with no clear trigger, it’s reasonable to ask your doctor about a PSA test within a few weeks of completing antibiotic treatment. The three-month post-infection window is when cancer detection risk is highest in the research.
Are recurrent UTIs more concerning than a single infection?
Yes. Recurrent infections create ongoing cycles of inflammation that may gradually affect prostate tissue. Two or more infections within six months warrants a more thorough urological evaluation.
Can I reduce my risk through lifestyle changes?
Good hydration, regular physical activity, maintaining a healthy weight, and managing blood sugar all support both urinary and prostate health. These steps won’t eliminate genetic or age-related risk, but they address modifiable factors that compound over time.
Conclusion
Bladder infection may increase prostate cancer risk; the evidence is real, though it’s observational and still developing. The sharpest risk window falls within three months of a cystitis diagnosis, which is why prompt medical evaluation matters, especially for men over 50. Tackling inflammation through consistent lifestyle habits and active management of recurrent infections is the most practical long-term protective step. Talk to your healthcare provider if you’ve had a recent or repeated bladder infection; a straightforward PSA conversation could make all the difference.
This article is for informational purposes only and does not serve as medical advice. The details provided here are not a replacement for, and should never be depended upon as, professional medical advice. Always consult your physician regarding the potential risks and benefits of any treatment.
Dr. Chinedu Anthony Anene
PhD, Senior Lecturer in Bioinformatics
Dr. Chinedu Anthony Anene, PhD, is a Senior Lecturer in Bioinformatics at Leeds Beckett University with expertise in cancer genomics, prostate cancer research, and computational biology.
Our Medical Review Process
At Ben’s Natural Health, we are committed to maintaining the highest standards of accuracy, transparency, and scientific integrity. Every piece of content is carefully developed by medical professionals and undergoes a thorough review every 12 to 24 months. This ensures that our information remains current, reliable, and rooted in credible, evidence-based research. We reference only peer-reviewed studies from reputable medical journals, providing full citations and direct links to enhance trust and confidence. Learn more about our medical review process and research standards.
Our Editorial Guidelines
For over 25 years, Ben’s Natural Health has been a trusted source of scientifically backed, reliable health information. Our editorial guidelines uphold the highest quality and integrity for every article we publish. Each piece is written by qualified experts and undergoes independent quality checks. We prioritize transparency by clearly displaying contributor credentials and biographies at the beginning of every article. Read more about our editorial standards.
Medical Disclaimer
The content on this blog is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. While our articles are authored and reviewed by licensed medical professionals, they may not address your specific health concerns. Always consult a qualified healthcare provider before making any medical decisions.
Article Sources
- Bladder Infection? It May Increase Prostate Cancer Risk – Sperling Prostate Center. Sperling Prostate Center. https://sperlingprostatecenter.com/bladder-infection-may-increase-prostate-cancer-risk/
- https://gamh.org/wp-content/uploads/2025/06/prostate_cancer_2025_12pp-FINALwebpdf.pdf
- https://doaj.org/article/59db8439de36487eae85c51d3d4dead5
- Common bladder infection may signal urogenital cancer risk. News-Medical. https://www.news-medical.net/news/20250917/New-study-links-cystitis-to-higher-risk-of-urogenital-cancers.aspx
- Chao-Yueh Fan, Wen-Yen Huang, Kuen-Tze Lin, Chun-Shu Lin, Hsing-Lung Chao, Jen-Fu Yang, et al. (2017). Lower Urinary Tract Infection and Subsequent Risk of Prostate Cancer: A Nationwide Population-Based Cohort Study. PLOS ONE, 12(1), e0168254. https://doi.org/10.1371/journal.pone.0168254
- Pan SY, Chen WC, Huang CP, Hsu CY, & Chang YH (2023). The Association of Prostate Cancer and Urinary Tract Infections: A New Perspective of Prostate Cancer Pathogenesis. Medicina (Kaunas, Lithuania), 59(3). https://doi.org/10.3390/medicina59030483
- Widding, Jeppe Lyngbye, Stroomberg, Hein Vincent, Dalton, Susanne Oksbjerg, Brasso, Klaus, Røder, Andreas, & Larsen, Signe Benzon (2026). The association between lower urinary tract symptoms and urinary tract infections, and subsequent prostate cancer workup: a nationwide population-based case-control study. British Journal of Cancer, 134(3), 486-492. https://doi.org/10.1038/s41416-025-03288-8
- https://ascopubs.org/doi/10.1200/JCO.2025.43.16_suppl.e17013
- Vermeulen, S H, Hanum, N, Grotenhuis, A J, Castaño-Vinyals, G, van der Heijden, A G, Aben, K K, et al. (2015). Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. British Journal of Cancer, 112(3), 594-600. https://doi.org/10.1038/bjc.2014.601
- https://doaj.org/article/80ef5053dae7481788bb9ad8a8d45b75
- Global Statistics on Prostate Cancer. Massive Bio. https://massivebio.com/global-statistics-on-prostate-cancer-bio/
- Zi H, Liu MY, Luo LS, Huang Q, Luo PC, Luan HH, et al. (2024). Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Military Medical Research, 11(1), 64. https://doi.org/10.1186/s40779-024-00569-w
- Do Urinary Symptoms Lead to Needless Prostate Cancer Tests?. Medscape. https://www.medscape.com/viewarticle/do-lower-urinary-tract-symptoms-lead-unnecessary-prostate-2025a1000ysr
- https://doaj.org/article/0c5764ea53164d83b84fc4513d731b14
- Zhao, Xiaohu, Liu, Shuchen, Zou, Zhihui, & Liang, Chaozhao (2025). Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analyses. Frontiers in Public Health, 13, 1595159. https://doi.org/10.3389/fpubh.2025.1595159
Article Update History
Reviewer:
Created on June 5, 2021
Explore More

New Guidelines On Prostate Cancer Screening For Black Men
The goal of prostate cancer screening is to detect it early and find it before it spreads and causes symptoms. Late detection can lead ...